CardioGenics Holdings Inc. 4
4 · CardioGenics Holdings Inc. · Filed Jun 7, 2013
Insider Transaction Report
Form 4
STERLING LINDA J.
Director
Transactions
- Purchase
Convertible Debenture Series B
2013-06-03$30000.00/sh+1$30,000→ 1,666,617 totalExercise: $0.25From: 2013-06-03Exp: 2016-06-02→ Common Stock (120,000 underlying) - Purchase
Warrant
2013-06-03+1→ 0 totalExercise: $0.15From: 2013-06-03Exp: 2016-06-02→ Common Stock (45,000 underlying)
Footnotes (1)
- [F1]The Series B Convertible Debenture and Warrant were part of a fractional unit that included one (1) convertible debenture in the original principal amount of $30,000 and one (1) warrant to purchase 45,000 shares of common stock, for a unit purchase price of $30,000.